3Peduzzi P, Shatney C, Sheagren J, et al. Predictors of bacteremia and Gram-negative bacteremia in patients with sepsis [ J ]. Arch In- tern Med, 1992,152 (3) :529 - 535.
4Petitjean s, Assicot M, Etude I. Immunreactivite calcitonine like au cours des proeessus infectieux [ M ]. Paris: Diplome detudes appro- fondiesde biotechnolosie universite Paris V, 1995.9 - 18.
5Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin con- centrations in patients with sepsis and infection [ J ]. Lancet, 1993, 341 (8844) :515 -518.
6Mtiller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit [ J ]. Crit Care Med,2000,28(4) :977 -983.
7Vincent JL. Procalcitonin: The marker of sepsis? [ J]. Crit Care Med ,2000,28 (4) : 1226 - 1228.
9GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
10Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
